The Latest Breaking News from PFE

Sky-rocketing inflation and the Fed’s hawkish tilt have led to an economic slowdown. However, a decent start to the corporate earnings season is lifting investors’ optimism. And we think it will not be wise for investors to ignore fundamentally solid stocks such as Pfizer (PFE) and Kroger (KR), currently trading…

The Fed's consecutive aggressive interest rate hikes to combat record-high inflation have led to heightened volatility in the market. Dividend stocks could be ideal investments to generate stable income amid such unstable market conditions. Therefore, investors could consider buying fundamentally sound dividend stocks Pfizer (PFE), ICL Group (ICL), and Karooooo…

With inflation showing no sign of cooling down, the Fed is expected to continue with its rate hikes, raising the chances of a recession. Healthcare stocks have historically provided a cushion in such hazy times. Hence, fundamentally robust stocks Johnson & Johnson (JNJ) and Pfizer (PFE) might be safe additions…

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The Fed's consistent rate hikes have wreaked havoc across markets. However, fundamentally solid stocks Pfizer (PFE) and CVS Health (CVS) survived the market volatility pretty well. While these stocks are good additions to your portfolio, you would have benefited more had you invested in them earlier. Read on….

Despite widespread recession concerns, Jim Cramer believes that the market could see an outsized rally in the near term as per historical trends. Given this backdrop, we think investors should load up Pfizer (PFE), Stellantis (STLA), APA Corporation (APA), Ryerson Holding (RYI), and Forrester Research (FORR), which are trading under…

The stock market is experiencing a broad sell-off due to the Fed’s hawkish rate hikes and rising recession odds. As healthcare stocks are considered safe haven amid market turbulence, we think fundamentally sound Johnson & Johnson (JNJ) and Pfizer (PFE), which also have a significant dividend-paying record, could be solid…

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Raging inflation and the Fed’s continued rate hikes have kept the stock market under tremendous pressure. Healthcare stocks have always been considered safe haven amid market uncertainties, and we think fundamentally solid stocks AbbVie (ABBV), Pfizer (PFE), and McKesson Corporation (MCK) could be ideal buys for the long term. Read…

The Fed’s successive rate hikes have hit household wealth. Moreover, rate hikes against a slowing economic backdrop have increased the risk of recession. Amid this, we believe stable dividend stocks Pfizer (PFE), Merck & Co. (MRK), and Valero Energy (VLO) might be ideal investments. Read more….

The interest rate hikes by central banks around the globe might slow down the global economy. However, staying invested in resilient and dividend-yielding stocks could help garner significant returns in the long run. To that end, Johnson & Johnson (JNJ), Pfizer (PFE), and Ryerson Holding Corporation (RYI) could be ideal…